1627607-87-7
Chemical Structure
PFI-2 hydrochloride
Synonym(s): (R)-PFI-2 hydrochloride
- CAS No.: 1627607-87-7
- Formula:C23H26ClF4N3O3S
- Molecular Weight:535.98
IUPAC Name: (R)-8-fluoro-N-(1-oxo-1-(pyrrolidin-1-yl)-3-(3-(trifluoromethyl)phenyl)propan-2-yl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide hydrochloride
InChIKey: ZADKZNVAJGEFLC-ZMBIFBSDSA-N
SMILES: O=S(C1=CC2=C(CNCC2)C(F)=C1)(N[C@H](CC3=CC=CC(C(F)(F)F)=C3)C(N4CCCC4)=O)=O.[H]Cl
Biological Activity: PFI-2 ((R)-PFI-2 hydrochloride) hydrochloride is a potent and selective SET domain containing lysine methyltransferase 7 (SETD7) inhibitor. (R)-PFI-2 shows high inhibiting activity with IC50 value of 2.0 nM and (S)-PFI-2 shows inhibiting activity with IC50 value of 1.0 μM. PFI-2 hydrochloride can be used for the research of chronic kidney disease and inflammation response in the development of renal fibrosis[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PFI-2 hydrochloride | 99.48% | PFI-2 ((R)-PFI-2 hydrochloride) hydrochloride is a potent and selective SET domain containing lysine methyltransferase 7 (SETD7) inhibitor. (R)-PFI-2 shows high inhibiting activity with IC50 value of 2.0 nM and (S)-PFI-2 shows inhibiting activity with IC50 value of 1.0 μM. PFI-2 hydrochloride can be used for the research of chronic kidney disease and inflammation response in the development of renal fibrosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 1.00
HY-110196(S)-PFI-2 hydrochloride -
Similarity Score 0.99
HY-18627PFI-2 -
Similarity Score 0.50
HY-161902MI-1904 -
Similarity Score 0.50
HY-130837JH-LPH-28 -
Similarity Score 0.50
HY-W783268Matriptase-IN-2 free base -
Similarity Score 0.50
HY-130836LpxH-IN-AZ1 -
Similarity Score 0.49
HY-130838JH-LPH-33 -
Similarity Score 0.48
HY-174285NAPAP -
Similarity Score 0.48
HY-100415UKI-1 -
Explore the MedChemAI to find more analogs
References
- [1]. Yuzhen Niu, et al. Revealing inhibition difference between PFI-2 enantiomers against SETD7 by molecular dynamics simulations, binding free energy calculations and unbinding pathway analysis. Sci Rep. 2017 Apr 18;7:46547. [Content Brief]
- [2]. Benquan Liu, et al. Pharmacological inhibition of SETD7 by PFI-2 attenuates renal fibrosis following folic acid and obstruction injury. Eur J Pharmacol. 2021 Jun 15;901:174097. [Content Brief]
